Literature DB >> 19440721

[Central scotoma and blurred vision in a patient with Crohn's disease].

A Caramoy1, A Lappas, S Fauser, B Kirchhof.   

Abstract

A 42-year-old male patient was transferred as an emergency with suspected retrobulbar neuritis due to a central scotoma. He had suffered from reduced vision in the right eye in the past. The diagnosis was chronic recurrent retinopathy centralis serosa due to many years of corticosteroid intake for bronchial asthma and Crohn's disease. Photodynamic therapy was carried out on the right eye and the corticosteroids were discontinued.

Entities:  

Mesh:

Year:  2009        PMID: 19440721     DOI: 10.1007/s00347-009-1950-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  4 in total

Review 1.  Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies.

Authors:  Lee M Jampol; Robert Weinreb; Lawrence Yannuzzi
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

2.  [Diffuse retinal pigmented epitheliopathy associated with systemic corticosteroid therapy].

Authors:  C W Spraul; M J Jakobczyk-Zmija; G K Lang; G E Lang
Journal:  Klin Monbl Augenheilkd       Date:  2000-06       Impact factor: 0.700

Review 3.  Central serous chorioretinopathy.

Authors:  Maria Wang; Inger Christine Munch; Pascal W Hasler; Christian Prünte; Michael Larsen
Journal:  Acta Ophthalmol       Date:  2007-07-28       Impact factor: 3.761

4.  Chronic retinal pigment epithelial detachments with unusual clinical, angiographic, and tomographic presentations.

Authors:  Dhananjay Shukla; Anand Rajendran; Somnath Chakraborty; Rajkumar Maheshwari
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2008 Nov-Dec
  4 in total
  1 in total

1.  Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era.

Authors:  Alix Cuny; Lucas Guillo; Cédric Baumann; Patrick Netter; Silvio Danese; Bénédicte Caron; Laurent Peyrin-Biroulet; Karine Angioi
Journal:  J Clin Med       Date:  2022-08-04       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.